Board Brief
The Board Brief — Monday, September 28, 2026
The Board Brief Monday, September 28, 2026 · 7 stories worth your attention Kyverna cell therapy shows sustained benefit in autoimmune disease Why it matters: Reports that many treated patients remained off other therapies suggest cell therapy could change how some autoimmune conditions are managed. Boards should distinguish that potential from